About US
Contact us
-
Sanofi crowdsources tweaks to social media strategySocial media may be a potential minefield for Big Pharma, but some companies are finding their way safely. One of them is Sanofi ($SNY), which recovered from a Facebook slap from a disgruntled patie2012/8/22
-
GSK to buy in APIs rather than keep Indian plant runningGlaxoSmithKline ($GSK) will turn to outsourcing to replace APIs made at an Indian plant on its way to closure. Rather than sink more capital into improving the Thane, India, plant, the company will2012/8/22
-
Drug Safety Blacklist Management Rules (interim) to be implemented on October 1The State Food and Drug Administration issued the Drug Safety Blacklist Management Rules (interim) on August 14, 2012. According to the Management Rules, relevant information of producers, operators a2012/8/21
-
Predictions for emerging markets hit new realitiesFor several years now, Eli Lilly ($LLY) has been telling shareholders that China would pay off big time for the drugmaker. Its plan was to be the fastest-growing company in Big Pharma, reaping sales f2012/8/21
-
Novartis, India face off over patent-protection future thereIt is the moment of truth for Novartis ($NVS) and its widely watched patent fight with India. But while this case is over its groundbreaking cancer treatment Gleevec, it will define what kind of intel2012/8/21
-
Roche runs short on Boniva after overestimating generic erosionMany companies have been caught off-guard by the extent to which generic competition has eaten away at their sales. Genentech says it managed to be caught by surprise, however, by a lack thereof; lead2012/8/20
-
India's per-capita pricing proposal could ripple through emerging marketsThe Indian government's proposal to link drug prices with per capita income could cut some branded drug prices by one-third. That makes some European price cuts look mild. But according to The Eco2012/8/20
-
Lilly takes the lead in DTC ad spending, surpassing PfizerEli Lilly ($LLY) has overtaken Pfizer ($PFE) in the pharma advertising steeplechase. Cegedim Strategic Data reports that Lilly's spending on direct-to-consumer advertising surpassed Pfizer's in Apri2012/8/17
-
U.K. docs don't see sales reps, and don't use pharma's websites, eitherWhile U.S. doctors are seeing more pharma reps with iPads in hand, U.K. doctors are seeing fewer pharma reps, period. According to a recent survey reported at PMLive, more than half of general p2012/8/17
-
New pharma trial: Pfizer, GSK, J&J test 1-page drug information sheetsBy Eric Palmer While drug labels get lots of FDA attention, drug information sheets have gotten very little--until now. With the blessing of the FDA, three of pharma's biggest companies are testi2012/8/16